IP Library Granted Patent US 8,926,555
Granted Patent B2
US 8,926,555 · App. 13/869,822 · Granted Jan 6, 2015

Power injector with flow rate assessment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,926,555
App. No.
13/869,822
Granted
Jan 6, 2015
Kind
B2
Abstract

A flow rate assessment protocol ( 140 ) that may be utilized by a power injector ( 10 ) is disclosed. This flow rate assessment protocol ( 140 ) monitors a flow rate ( 156 ) during execution of a medical fluid delivery protocol ( 154 ). This monitored flow rate is compared with a target flow rate ( 158 ). A comparative output of this monitored flow rate and target flow rate is displayed ( 160 ), for instance on a graphical user interface ( 11 ).

Claims (35)

1. A power injector, comprising:

a powerhead;

a syringe plunger driver;

a graphical user interface; and

control logic configured to: a) execute a medical fluid delivery protocol, wherein said medical fluid delivery protocol comprises at least one phase configured to deliver a programmed volume of a medical fluid at a programmed target flow rate, and wherein said power injector attempts to provide said target flow rate in an execution of said at least one phase; and b) display a first output on said graphical user interface, wherein said first output comprises a numerical representation of a relationship between said target flow rate of said at least one phase of said medical fluid delivery protocol and a current flow rate that exists during an execution of said at least one phase of said medical fluid delivery protocol, wherein said numerical representation comprises a single number.

2. The power injector of claim 1 , wherein said first output is presented on said graphical user interface only when said current flow rate differs from said target flow rate by more than a predetermined amount.

3. The power injector of claim 1 , wherein said first output is presented on said graphical user interface throughout execution of said medical fluid delivery protocol.

4. The power injector of claim 1 , wherein said numerical representation comprises an expression of said current flow rate as a percentage of said target flow rate.

5. The power injector of claim 1 , wherein said numerical representation comprises a differential between said current flow rate and said target flow rate.

6. The power injector of claim 1 , wherein said first output comprises a contrast between said current flow rate with said target flow rate.

7. The power injector of claim 1 , wherein said first output comprises information as to how said current flow rate differs from said target flow rate.

8. The power injector of claim 1 , further comprising:

a message, in addition to said first output, that conveys that said current flow rate is failing to comply with said target flow rate.

9. The power injector of claim 1 , further comprising:

a data entry device operatively interconnected with said control logic.

10. The power injector of claim 9 , wherein said control logic is configured to store a termination condition that may be input by said data entry device, wherein said control logic terminates said medical fluid delivery protocol upon any occurrence of said termination condition.

11. The power injector of claim 10 , further comprising a prompt on said first graphical user interface to enter said termination condition.

12. The power injector of claim 9 , further comprising a prompt on said first graphical user interface to enter said target flow rate.

13. The power injector of claim 1 , wherein said control logic is configured to terminate said medical fluid delivery protocol if said current flow rate is less than a predetermined percentage of said target flow rate.

14. The power injector of claim 1 , wherein said control logic is configured to terminate said medical fluid delivery protocol if said current flow rate is less than said target flow rate by a flow rate value.

15. A power injector, comprising:

a powerhead;

a syringe plunger driver;

a graphical user interface; and

control logic configured to: a) execute a medical fluid delivery protocol, wherein said medical fluid delivery protocol comprises at least one phase configured to deliver a programmed volume of a medical fluid at a programmed target flow rate, and wherein said power injector attempts to provide said target flow rate in an execution of said at least one phase; and b) display a first output on said graphical user interface, wherein said first output comprises a numerical representation of a relationship between said target flow rate of said at least one phase of said medical fluid delivery protocol and a current flow rate that exists during an execution of said at least one phase of said medical fluid delivery protocol, wherein said numerical representation comprises an expression of said current flow rate as a percentage of said target flow rate.

16. The power injector of claim 15 , wherein said control logic is further configured to: c) discontinue execution of said medical fluid delivery protocol upon occurrence of a first flow rate variance between said target flow rate and said current flow rate; and d) generate a message, in addition to said first output, upon occurrence of a second flow rate variance between said target flow rate and said current flow rate, wherein said second flow rate variance is of a smaller magnitude than said first flow rate variance.

17. A power injector, comprising:

a powerhead;

a syringe plunger driver;

a graphical user interface;

a data entry device; and

control logic configured to: a) execute a medical fluid delivery protocol, wherein said medical fluid delivery protocol comprises at least one phase configured to deliver a programmed volume of a medical fluid at a programmed target flow rate, and wherein said power injector attempts to provide said target flow rate in an execution of said at least one phase; b) display a first output on said graphical user interface, wherein said first output is comparative of said target flow rate of said at least one phase of said medical fluid delivery protocol and a current flow rate that exists during an execution of said at least one phase of said medical fluid delivery protocol; c) discontinue execution of said medical fluid delivery protocol upon occurrence of a first flow rate variance between said target flow rate and said current flow rate; and d) generate a message, in addition to said first output, upon occurrence of a second flow rate variance between said target flow rate and said current flow rate, wherein said second flow rate variance is of a smaller magnitude than said first flow rate variance.

18. The power injector of claim 17 , wherein said control logic is further configured to prompt for entry of said second flow rate variance on said graphical user interface.

19. The power injector of claim 17 , wherein said first output is selected from the group consisting of: a) a separate numerical value for each of said target flow rate and said current flow rate; b) a numerical differential between said current flow rate and said target flow rate; and c) a numerical expression of said current flow rate as a percentage of said target flow rate.

20. The power injector of claim 17 , wherein discontinued execution of said medical fluid delivery protocol is one of a suspension of said medical fluid delivery protocol and a termination of said medical fluid delivery protocol.

Assignments (4)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →